⸺ Synova Research
Semax
Synthetic heptapeptide derived from ACTH studied for neuroprotection, cognition, focus and BDNF expression in preclinical models.
Secure checkout via UK open banking. Free shipping on orders over £100.
Independently tested
COA on request
Next-day UK dispatch
Order before midnight
Research use only
Not for human consumption
⸺ Important
- • Peptides sold in lyophilized form
- • Strictly for laboratory research
⸺ Overview
About Semax
Semax is a synthetic heptapeptide based on a fragment of adrenocorticotropic hormone (ACTH 4-10). Researchers study it for its neuroprotective and nootropic properties, including effects on BDNF expression, cognitive performance and recovery in neurological injury models.
⸺ Mechanism of Action
How it works
Semax modulates expression of BDNF and NGF, influences monoaminergic systems and shows neuroprotective effects via reduced oxidative stress in neural tissue. In animal models, this translates to improved learning, memory and resilience to ischemic injury.
⸺ Research
Areas of study
BDNF and neurotrophic signalling
Rodent studies report upregulated BDNF expression in hippocampus and cortex following Semax administration.
Cognitive performance
Preclinical work describes improved learning and memory performance in stressed and aged rodent models.
Neuroprotection
Research in ischemic stroke models has shown reduced infarct size and improved functional recovery.
Summarised from preclinical literature for informational purposes only. Not medical or veterinary advice. Synova Research products are sold strictly for in-vitro and laboratory research.
⸺ Details
Specification
- CAS
- 80714-61-0
- Intended use
- Research use only.
- Storage
- Lyophilised: cool, dry, dark. Reconstituted: refrigerate at 2–8°C.
- Solubility
- Vial holds up to 3mL.
- Shelf life
- Lyophilised: up to 24 months. Reconstituted: 4–6 weeks refrigerated.
- Handling
- Maintain sterile technique.
You might also research
View all →
R3TA
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied in animal models for appetite control, energy expenditure and glucose balance.
T1RZ
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.